101 related articles for article (PubMed ID: 22115571)
1. Anaphylaxis to lansoprazole with tolerance to omeprazole.
Aksu K; Kurt E
Allergol Immunopathol (Madr); 2012; 40(6):393-4. PubMed ID: 22115571
[No Abstract] [Full Text] [Related]
2. Hypersensitivity to lansoprazole with tolerance to other proton pump inhibitors: does cross-reactivity between proton pump inhibitors really exist?
Karabacak E; Kutlu A; Aydin E; Ozturk S
Allergol Immunopathol (Madr); 2013; 41(2):136-7. PubMed ID: 23137870
[No Abstract] [Full Text] [Related]
3. Immunoglobulin E-mediated anaphylaxis to rabeprazole.
Vovolis V; Christogianni K; Koutsostathis N
J Investig Allergol Clin Immunol; 2010; 20(4):360-1. PubMed ID: 20815321
[No Abstract] [Full Text] [Related]
4. Lack of pharmacokinetic interaction between omeprazole or lansoprazole and ivabradine in healthy volunteers: an open-label, randomized, crossover, pharmacokinetic interaction clinical trial.
Portolés A; Calvo A; Terleira A; Laredo L; Resplandy G; Gorostiaga C; Moreno A
J Clin Pharmacol; 2006 Oct; 46(10):1195-203. PubMed ID: 16988209
[TBL] [Abstract][Full Text] [Related]
5. [Lansoprazole--profile of a new proton pump inhibitor].
Seifert E
Leber Magen Darm; 1994 Mar; 24(2):66-8, 71. PubMed ID: 8196467
[TBL] [Abstract][Full Text] [Related]
6. Late-onset omeprazole-associated acute interstitial nephritis.
Ni N; Moeckel GW; Kumar C
J Am Geriatr Soc; 2010 Dec; 58(12):2443-4. PubMed ID: 21143456
[No Abstract] [Full Text] [Related]
7. Lansoprazole and glottis edema.
Pérez Roldán F; de los Ríos IL; Rodríguez Quinzaños E
Am J Gastroenterol; 1999 Jul; 94(7):1995. PubMed ID: 10406293
[No Abstract] [Full Text] [Related]
8. [Four kinds of new triple therapy regiments for Helicobacter pylori eradication in patients with peptic ulcer].
Shirai T; Kurumada T; Kouda K; Watanabe S; Tada U; Wada T; Takagi A; Harasawa S; Miwa T
Nihon Rinsho; 1999 Jan; 57(1):140-3. PubMed ID: 10036951
[No Abstract] [Full Text] [Related]
9. Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial.
Chey WD; Fisher L; Elta GH; Barnett JL; Nostrant T; DelValle J; Hasler WL; Scheiman JM
Am J Gastroenterol; 1997 Sep; 92(9):1483-6. PubMed ID: 9317068
[TBL] [Abstract][Full Text] [Related]
10. An in vitro comparison of different providers to deliver four proton pump inhibitor products through a feeding tube.
Devlin JW; Bakshi A; Bungay K; Olsen KM
Aliment Pharmacol Ther; 2006 Dec; 24(11-12):1603-11. PubMed ID: 17206948
[TBL] [Abstract][Full Text] [Related]
11. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
[TBL] [Abstract][Full Text] [Related]
12. [Proton pump inhibitor for ulcer therapy. Tolerance profile of lansoprazole].
Müller P; Fuchs W; Peifer-Weiss A; Simon B
Fortschr Med; 1998 Oct; 116(28):31-2. PubMed ID: 9844264
[No Abstract] [Full Text] [Related]
13. Intermittent use of pantoprazole and famotidine in severe hypomagnesaemia due to omeprazole.
Fernández-Fernández FJ; Sesma P; Caínzos-Romero T; Ferreira-González L
Neth J Med; 2010 Oct; 68(10):329-30. PubMed ID: 21071783
[No Abstract] [Full Text] [Related]
14. Omeprazole-Mg 20.6 mg is superior to lansoprazole 15 mg for control of gastric acid: a comparison of over-the-counter doses of proton pump inhibitors.
Miner PB; McKean LA; Gibb RD; Erasala GN; Ramsey DL; McRorie JW
Aliment Pharmacol Ther; 2010 Apr; 31(8):846-51. PubMed ID: 20146702
[TBL] [Abstract][Full Text] [Related]
15. [What are the indications for proton pump inhibitors? R. Arnold, Marburg, elaborates on the clinical aspects of the controversy regarding lansoprazole. Interview by Gerrit Lichtenberg].
Arnold R
Fortschr Med; 1994 Jan; 112(1-2):44-5. PubMed ID: 8144120
[No Abstract] [Full Text] [Related]
16. The influence of pretreatment on cure rates of Helicobacter pylori eradication.
Janssen MJ; Laheij RJ; Jansen JB; de Boer WA
Neth J Med; 2004 Jun; 62(6):192-6. PubMed ID: 15460498
[TBL] [Abstract][Full Text] [Related]
17. [Rapidity of pain relief, medication requirement and patient satisfaction with reflux treatment in the physician's office].
Dohmen W; Fuchs W
MMW Fortschr Med; 2005 Apr; 147 Suppl 1():21-5. PubMed ID: 16739368
[TBL] [Abstract][Full Text] [Related]
18. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
[TBL] [Abstract][Full Text] [Related]
19. Dual therapy with lansoprazole and clarithromycin for eradication of Helicobacter pylori.
Takimoto T; Kimura K; Taniguchi Y; Satoh K; Saifuku K; Kihira K; Yoshida Y; Ido K
Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S63-6. PubMed ID: 8574739
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of lansoprazole (30 mg) and omeprazole (20 mg) in the treatment of duodenal ulcer. A multicenter double-blind comparative trial].
Petite JP; Slama JL; Licht H; Lemerez M; Coste T; Andrieu J; Grimaud JC; Julien H; Dupuis J; Sallerin V
Gastroenterol Clin Biol; 1993; 17(5):334-40. PubMed ID: 8349067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
